SOLV
SolventumCNYSE / Health Care Equipment & Services
Last Price
At close
2026-07-22
Current thesis
Execution on new product ramps and margin expansion plus stable end-market demand could re-rate the stock toward premium specialty-chemical multiples, supporting a >40% upside to the anchor.
Posture
Mixed
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta -4.4.
What can break
A sustained raw-material price shock, missed commercial ramps, or weaker end-market demand could push valuation down materially; illiquidity could amplify downside.
Momentum
39
Value
51
Sentiment
64
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $95.00 · Bull $120.00 · Bear $60.00
Data freshness
Prices
As of 2026-07-22
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-22 • Model: HYBRID_IC_RP
AI Memo
As of 2025-11-27 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-07-22
Investment thesis
As of 2026-07-22
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $84.42
Why
Momentum39 · Δ7d +25.3
Value51 · Δ7d -0.0
Sentiment64 · Δ7d -4.4
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Sentiment · See AI snapshot
Momentum
39
26% active weight
Current posture
7d trendFlat
Δ7d
+25.3
Δ21d
-9.3
Value
51
39% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.2
Sentiment
64
34% active weight
Current posture
7d trendSoftening
Δ7d
-4.4
Δ21d
-3.6
Why this grade
Composite grade C. Momentum 39.2 / Value 51.1 / Sentiment 64.5
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$13.72B
Beta
-
Shares Out
173.17M
P/E (TTM)
9.3
P/S (TTM)
1.67
P/FCF (TTM)
280.29
Rev YoY
-3.0%
EPS YoY
-90.5%
Gross Margin
+56.6%
Op Margin
+25.1%
Net Debt
$4.37B
Current Ratio
1.07
As of 2026-07-22 • Updated nightlySource: Internal modelMethodology